Experts address COVID-19 vaccine myths, safety evidence, and how to frame the benefits of vaccination in pregnancy.
|Articles|September 23, 2020
Congenital cytomegalovirus may be leading cause of microcephaly
Author(s)Lindsey Carr, Editor
A new study in JAMA Pediatrics analyzed the number of microcephaly cases that resulted from congenital microcephaly and how it may be a larger cause than the 2016 Zika epidemic.
Advertisement
Researchers ultimately found that congenital cytomegalovirus infection significantly increased the prevalence of microcephaly at delivery 7-fold. These findings suggest that preventing cytomegalovirus in pregnancy may substantially reduce the number of babies with microcephaly at birth.
For a detailed study summary, visit
Advertisement
Related to this article
Experts look ahead to new maternal vaccines and how to counsel patients on receiving several in one pregnancy.
Experts discuss common patient concerns about vaccination in pregnancy and strategies to improve uptake.
Experts discuss how obstetric and pediatric clinicians can coordinate to protect newborns.
Experts review ACOG's 2026-27 guidance and the RSV window extension for pregnant and postpartum patients.
On September 9, 2026, certolizumab pegol received FDA Breakthrough Therapy Designation for APS pregnancy; Jane E. Salmon, MD, reviews the IMPACT trial results behind it.
Garima Sharma, MD, outlines validated cardiac risk scores for antenatal screening and the postpartum transitions needed to keep high-risk patients from being lost to follow-up.
Anti-CGRP antibody exposure in early pregnancy was linked to higher spontaneous abortion risk; propranolol was not.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Before Pregnancy Begins: Why the Timing of Carrier Screening Matters
2
JoAnn V. Pinkerton, MD, MSCP, on elinzanetant across menopause subpopulations at TMS 2026
3
Brain fog at menopause: Separating normal change from dementia
4
What to expect at The Menopause Society's 2026 Annual Meeting
5